Opinion · 22 Oct 2024
Research articlePublished 29 Sep 2022
In Silico Molecular Docking Analysis of Potential Anti-Alzheimer's Compounds Present in Occimum Santum
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: Alzheimer’s disease (AD), a progressive neurodegenerative disorder with many cognitive and neuropsychiatric symptoms, is biochemically characterized by a significant decrease in the brain neurotransmitter Acetylcholine (ACh). Methods: : In the present insilico study, four plant bioactive compounds of Ocimum sanctum were analyzed for their inhibitory role on AChE (Acetylcholinesterase) and BChE (Butyrylcholinesterase) activity by applying the molecular docking studies. Other parameters viz. determination of molecular interaction-based binding affinity values, protein-ligand interactions, Lipinski rule of five, functional properties and biological activities for the above compounds were also calculated by employing the appropriate bioinformatics tools. The active compounds is to reveal its potentiality by molecular docking analysis to find out its potent compound against alzheimer’s disease which was done by Lipinski's rule in docking analysis. Results: A wide range of docking score found during molecular docking analysis. Among the compounds Eugenol, α – Farnesene, Benzene, 1, 2- dimethoxy-4-(1- propenyl) and Cyclohexane, 1, 2, 4-triethenyl is found to be a good inhibitor of 4 well-known drug targets. This is an effective lead molecule that can be used in the treatment of Alzheimer’s disease.The results of docking analysis clearly showed that Cyclohexane-1, 2, 4-triethenyl has highest binding affinity with AChE and BChE Conclusion: Cyclohexane-1, 2, 4-triethenyl and other compounds are inhibiting of both, as it possessed best value in Molecular docking hence these are the potent anti-alzheimer's agent.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dr. Susanta Kumar Rout”
- BylineArticles whose byline prints “Ms. Farhin Nikhat”
- BylineArticles whose byline prints “Sabyasachi Mohanty”
